Evaluation of Matrix metalloproteinases-2 (MMP-2) and Tissue inhibitors of metalloproteinases-2 (TIMP-2) in Oral Submucous Fibrosis and their correlation with disease severity

A. Shrestha, Sunitha Carnelio

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Oral submucous fibrosis (OSF), a potentially malignant oral lesion, is a form of pathological fibrosis affecting the oral mucosa. It results from an imbalance in equilibrium of the normal process of synthesis and degradation of extra cellular matrix. Matrix metalloproteinases and its inhibitors play important role in remodeling of the extra cellular matrix which are important in progression and pathogenesis of potentially malignant lesions to malignancy. Objectives: To evaluate the expression and distribution of Matrix metalloproteinases-2 (MMP-2) and Tissue inhibitor of metalloproteinases-2 (TIMP-2) in different grades of Oral Submucous Fibrosis(OSF). Method: Immunohistochemical analysis for MMP-2 and its TIMP-2 was performed in 30 histopathologically confirmed, formalin fixed, paraffin embedded specimens of OSF. A semi-quantitative analysis was done to assess the expression, distribution and comparison of these in various stages of this disease. Result: All moderately advanced cases and 64.2% for MMP-2 and 78.5% for TIMP-2 of early stage cases showed positivity. Between two stages of OSF, statistically significant differences were noted in expression of TIMP-2 in lamina propria, deep connective tissue and supra basal layers (p<0.05) and basal and supra basal layers for MMP-2 (p<0.05). Conclusion: The simultaneous increase in expression of MMP-2 and TIMP-2 with advancing stages of OSF can provide a basis for considering the proteases as important mediators in the pathogenesis and progression of OSF which could aid in identifying the aggressiveness of the condition and elucidate its role in its malignant transformation.

Original languageEnglish
Pages (from-to)274-281
Number of pages8
JournalKathmandu University Medical Journal
Volume11
Issue number44
Publication statusPublished - 01-01-2013

Fingerprint

Oral Submucous Fibrosis
Tissue Inhibitor of Metalloproteinase-2
Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinase 2
Mouth Mucosa
Paraffin
Connective Tissue
Formaldehyde
Mucous Membrane
Fibrosis
Peptide Hydrolases

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{8688b04ad54a408daf4b8e587c9218bb,
title = "Evaluation of Matrix metalloproteinases-2 (MMP-2) and Tissue inhibitors of metalloproteinases-2 (TIMP-2) in Oral Submucous Fibrosis and their correlation with disease severity",
abstract = "Background: Oral submucous fibrosis (OSF), a potentially malignant oral lesion, is a form of pathological fibrosis affecting the oral mucosa. It results from an imbalance in equilibrium of the normal process of synthesis and degradation of extra cellular matrix. Matrix metalloproteinases and its inhibitors play important role in remodeling of the extra cellular matrix which are important in progression and pathogenesis of potentially malignant lesions to malignancy. Objectives: To evaluate the expression and distribution of Matrix metalloproteinases-2 (MMP-2) and Tissue inhibitor of metalloproteinases-2 (TIMP-2) in different grades of Oral Submucous Fibrosis(OSF). Method: Immunohistochemical analysis for MMP-2 and its TIMP-2 was performed in 30 histopathologically confirmed, formalin fixed, paraffin embedded specimens of OSF. A semi-quantitative analysis was done to assess the expression, distribution and comparison of these in various stages of this disease. Result: All moderately advanced cases and 64.2{\%} for MMP-2 and 78.5{\%} for TIMP-2 of early stage cases showed positivity. Between two stages of OSF, statistically significant differences were noted in expression of TIMP-2 in lamina propria, deep connective tissue and supra basal layers (p<0.05) and basal and supra basal layers for MMP-2 (p<0.05). Conclusion: The simultaneous increase in expression of MMP-2 and TIMP-2 with advancing stages of OSF can provide a basis for considering the proteases as important mediators in the pathogenesis and progression of OSF which could aid in identifying the aggressiveness of the condition and elucidate its role in its malignant transformation.",
author = "A. Shrestha and Sunitha Carnelio",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "11",
pages = "274--281",
journal = "Kathmandu University Medical Journal",
issn = "1812-2027",
publisher = "Kathmandu University",
number = "44",

}

TY - JOUR

T1 - Evaluation of Matrix metalloproteinases-2 (MMP-2) and Tissue inhibitors of metalloproteinases-2 (TIMP-2) in Oral Submucous Fibrosis and their correlation with disease severity

AU - Shrestha, A.

AU - Carnelio, Sunitha

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background: Oral submucous fibrosis (OSF), a potentially malignant oral lesion, is a form of pathological fibrosis affecting the oral mucosa. It results from an imbalance in equilibrium of the normal process of synthesis and degradation of extra cellular matrix. Matrix metalloproteinases and its inhibitors play important role in remodeling of the extra cellular matrix which are important in progression and pathogenesis of potentially malignant lesions to malignancy. Objectives: To evaluate the expression and distribution of Matrix metalloproteinases-2 (MMP-2) and Tissue inhibitor of metalloproteinases-2 (TIMP-2) in different grades of Oral Submucous Fibrosis(OSF). Method: Immunohistochemical analysis for MMP-2 and its TIMP-2 was performed in 30 histopathologically confirmed, formalin fixed, paraffin embedded specimens of OSF. A semi-quantitative analysis was done to assess the expression, distribution and comparison of these in various stages of this disease. Result: All moderately advanced cases and 64.2% for MMP-2 and 78.5% for TIMP-2 of early stage cases showed positivity. Between two stages of OSF, statistically significant differences were noted in expression of TIMP-2 in lamina propria, deep connective tissue and supra basal layers (p<0.05) and basal and supra basal layers for MMP-2 (p<0.05). Conclusion: The simultaneous increase in expression of MMP-2 and TIMP-2 with advancing stages of OSF can provide a basis for considering the proteases as important mediators in the pathogenesis and progression of OSF which could aid in identifying the aggressiveness of the condition and elucidate its role in its malignant transformation.

AB - Background: Oral submucous fibrosis (OSF), a potentially malignant oral lesion, is a form of pathological fibrosis affecting the oral mucosa. It results from an imbalance in equilibrium of the normal process of synthesis and degradation of extra cellular matrix. Matrix metalloproteinases and its inhibitors play important role in remodeling of the extra cellular matrix which are important in progression and pathogenesis of potentially malignant lesions to malignancy. Objectives: To evaluate the expression and distribution of Matrix metalloproteinases-2 (MMP-2) and Tissue inhibitor of metalloproteinases-2 (TIMP-2) in different grades of Oral Submucous Fibrosis(OSF). Method: Immunohistochemical analysis for MMP-2 and its TIMP-2 was performed in 30 histopathologically confirmed, formalin fixed, paraffin embedded specimens of OSF. A semi-quantitative analysis was done to assess the expression, distribution and comparison of these in various stages of this disease. Result: All moderately advanced cases and 64.2% for MMP-2 and 78.5% for TIMP-2 of early stage cases showed positivity. Between two stages of OSF, statistically significant differences were noted in expression of TIMP-2 in lamina propria, deep connective tissue and supra basal layers (p<0.05) and basal and supra basal layers for MMP-2 (p<0.05). Conclusion: The simultaneous increase in expression of MMP-2 and TIMP-2 with advancing stages of OSF can provide a basis for considering the proteases as important mediators in the pathogenesis and progression of OSF which could aid in identifying the aggressiveness of the condition and elucidate its role in its malignant transformation.

UR - http://www.scopus.com/inward/record.url?scp=84901824184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901824184&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 274

EP - 281

JO - Kathmandu University Medical Journal

JF - Kathmandu University Medical Journal

SN - 1812-2027

IS - 44

ER -